Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06583837
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-31
Brief Title:
Orelabrutinib Followed by Response-adapted Ultra-low Dose 4Gy Radiation as First-line Treatment of MALT Lymphoma
Sponsor:
Organization:
None